Seiji Iwama Selected Research

BS 1417

7/2005

A Novel alphavbeta3 integrin antagonist suppresses neointima formation for more than 4 weeks after balloon injury in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seiji Iwama Research Topics

Disease

2	Epilepsy (Aura) 01/2017 - 01/2017
2	Neointima 07/2005 - 05/2004
1	Seizures (Absence Seizure) 01/2017

Drug/Important Bio-Agent (IBA)

1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2017
1	compound 21IBA 01/2017
1	Integrin alphaVbeta3IBA 07/2005
1	BS 1417IBA 07/2005
1	Integrin beta3 (GPIIIa)IBA 05/2004

Therapy/Procedure

2	Therapeutics 01/2017 - 01/2017
1	Subcutaneous Infusions 07/2005